You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

degarelix

Showing 1 - 25 of 87
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Prostatic Adenocarcinoma Trial in Charleston (Docetaxel, Degarelix)

Active, not recruiting
  • Metastatic Prostatic Adenocarcinoma
  • Charleston, South Carolina
    Medical University of South Carolina
Jan 30, 2023

Metastatic Castration Sensitive Prostate Cancer Trial in New York (Degarelix, Ipilimumab, Radical Prostatectomy)

Active, not recruiting
  • Metastatic Castration Sensitive Prostate Cancer
  • Degarelix
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 4, 2022

Urothelial Carcinoma Bladder, Androgen Receptor Positive Trial in Providence (Degarelix, Gemcitabine/Cisplatin)

Not yet recruiting
  • Urothelial Carcinoma Bladder
  • Androgen Receptor Positive
  • Degarelix
  • Gemcitabine/Cisplatin
  • Providence, Rhode Island
    Lifespan Cancer Institute
May 1, 2023

Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,

Not yet recruiting
  • Localized Prostate Carcinoma
  • +3 more
  • Degarelix
  • MRI-guided transurethral ultrasound ablation (TULSA)
  • Turku, Southwest Finland, Finland
    Turku University Hospital
Jun 14, 2023

Endometriosis Trial in Tirana, Sofia, Rome (degarelix, goserelin)

Completed
  • Endometriosis
  • Tirana, Albania
  • +2 more
Feb 10, 2022

Prostate Cancer Trial in New York (BMS-986218 and Degarelix, Degarelix)

Recruiting
  • Prostate Cancer
  • BMS-986218 and Degarelix
  • Degarelix
  • New York, New York
    Columbia University Irving Medical Center
Oct 27, 2021

Prostate Cancer Trial in Houston (177Lu rhPSMA-10.1, Degarelix)

Not yet recruiting
  • Prostate Cancer
  • 177Lu rhPSMA-10.1
  • Degarelix
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2023

Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)

Active, not recruiting
  • Leukemia
  • +3 more
  • Palifermin
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Prostate Cancer Trial in Madison (Docetaxel, Degarelix, Bicalutamide)

Completed
  • Prostate Cancer
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Sep 12, 2022

Prostate Cancer Trial (ADT, Enzalutamide, Talazoparib)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
May 15, 2023

Stage III Prostate Adenocarcinoma AJCC v7, Stage III Prostate Cancer AJCC v7, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in

Completed
Has Results
  • Stage III Prostate Adenocarcinoma AJCC v7
  • +3 more
  • Abiraterone Acetate
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 15, 2021

Radiation Therapy for Bladder Cancer

Recruiting
  • Bladder Cancer
  • +2 more
  • Degarelix
  • Aarhus, Denmark
    Aarhus University Hospital
Aug 5, 2022

Prostate Cancer Trial in United States (Abiraterone acetate, Abiraterone acetate plus degarelix, Degarelix)

Completed
Has Results
  • Prostate Cancer
  • Abiraterone acetate
  • +2 more
  • Chicago, Illinois
  • +15 more
Oct 25, 2021

Metastatic Prostate Cancer in Pirkanmaa Hospital District in

Not yet recruiting
  • Metastatic Castration Sensitive Prostate Cancer (mCSPC)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 17, 2023

Male Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma Trial in Boston

Not yet recruiting
  • Male Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 12, 2022

Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer Trial in Boston (Darolutamide, Abemaciclib, GNRH-A

Not yet recruiting
  • Metastatic Prostate Cancer
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 14, 2022

Prostate Cancer Trial in Madison (Degarelix, pTVG-AR, Nivolumab)

Recruiting
  • Prostate Cancer
  • Degarelix
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Jul 6, 2022

Prostate Cancer Trial in Los Angeles (degarelix, enzalutamide, trametinib)

Active, not recruiting
  • Prostate Cancer
  • degarelix
  • +3 more
  • Los Angeles, California
    University of California, Los Angeles
Aug 25, 2022

Prostate Cancer Metastatic Trial in New York (REGN2810, Degarelix, Leuprolide Acetate)

Recruiting
  • Prostate Cancer Metastatic
  • New York, New York
    Columbia University Irving Medical Center
Mar 22, 2022

Prostate Cancer Trial in India (Degarelix)

Completed
  • Prostate Cancer
  • Degarelix
  • Bikaner, Rajasthan, India
  • +18 more
Dec 14, 2021

Prostate Cancer, Neoadjuvant Therapy, Androgen Antagonists Trial in Leuven (ARN-509, Degarelix, Placebo)

Recruiting
  • Prostate Cancer
  • +3 more
  • Leuven, Vlaams-brabant, Belgium
    University Hospitals Leuven
Dec 23, 2020

Stage IV Prostate Cancer Trial in Baltimore (procedure, drug, other, biological)

Completed
Has Results
  • Stage IV Prostate Cancer
  • Cryosurgery
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Nov 11, 2021

Pregnancy, Ovarian Trial in Thessaloníki (Degarelix)

Recruiting
  • Pregnancy, Ovarian
  • Degarelix
  • Thessaloníki, Greece
    Assisting Nature
Oct 6, 2020

Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Stanford (radiation, drug, other)

Active, not recruiting
  • Prostate Adenocarcinoma
  • +4 more
  • Internal Radiation Therapy
  • +7 more
  • Stanford, California
    Stanford University, School of Medicine
Feb 1, 2022

Prostate Cancer Trial in United States (Degarelix, stereotactic body radiosurgery (SBRT))

Active, not recruiting
  • Prostate Cancer
  • Degarelix
  • stereotactic body radiosurgery (SBRT)
  • Miami, Florida
  • +9 more
Mar 1, 2022